Wilmington, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Closed System Drug Transfer Device (CSTD) Market by Type (Membrane to membrane and Needleless), Component (Barrier type CSTDs and Air cleaning CSTDs), and End User (Hospitals and Clinics, Oncology Centers and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023, and is estimated to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.
Request Sample of the Report on Closed System Drug Transfer Device (CSTD) Market 2033 - https://www.alliedmarketresearch.com/request-sample/A324072
Prime determinants of growth
Increasing prevalence of cancer cases and growing focus on worker safety are the major factors that drive the growth of the Closed System Drug Transfer Device (CSTD) market. However, high cost and maintain ace of devices hinders the market growth. Moreover, increased awareness of health risks offers remunerative opportunities for the expansion of the global Closed System Drug Transfer Device (CSTD) Market.
Report coverage & details
| Report Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $0.84 billion |
| Market Size in 2033 | $3.61 billion |
| CAGR | 15.7% |
| No. of Pages in Report | 216 |
| Segments Covered | Type, Component, End User, and Region |
| Drivers |
|
| Opportunities |
|
| Restraints |
|
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A324072
Segment Highlights
Membrane-to-membrane Closed System Drug Transfer Devices (CSTDs)
By type, Membrane-to-membrane Closed System Drug Transfer Devices (CSTDs) use a sealed, barrier membrane to connect two drug containers, ensuring that no contaminants enter or escape during drug transfer. This design minimizes exposure to hazardous drugs and protects healthcare workers from potential risks while maintaining sterile conditions.
Diaphragm based Component is preferred in Closed System Drug Transfer Devices (CSTDs)
By Component, Diaphragm-based Component in Closed System Drug Transfer Devices (CSTDs) is preferred due to its ability to provide a robust barrier against contamination and ensure secure drug transfer. The diaphragm acts as a seal between drug containers, preventing leaks and exposure to hazardous substances. This design enhances safety for healthcare workers and maintains the sterility of the medication.
Hospitals and clinics are the important end users of closed system drug transfer device (CSTD) 's
By end user, hospitals and clinics are key end users of Closed System Drug Transfer Devices (CSTDs) due to their critical role in handling and administering hazardous drugs. CSTDs are essential in these settings to protect healthcare workers from exposure to toxic substances, maintain drug sterility, and ensure patient safety. Their use is crucial for compliance with safety regulations and improving overall clinical outcomes.
Regional Outlook
Region wise, the Closed System Drug Transfer Device (CSTD) Market is expanding globally, with North America and Europe leading due to stringent regulations and high adoption rates. Asia-Pacific is witnessing significant growth driven by increasing healthcare infrastructure and rising awareness. Latin America and the Middle East are emerging markets, experiencing gradual adoption as regulatory frameworks strengthen and healthcare investments increase.
For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A324072
Key Players
- B. Braun Holding GmbH & Co. KG
- Baxter International
- Becton, Dickinson and Company
- Caragen Ltd.
- Corvida Medical
- Equashield
- FIMI Opportunity Funds (Simplivia Healthcare)
- ICU Medical
- JCB Co Ltd. (JMS Co Ltd.)
- Yukon Medical
The report provides a detailed analysis of these key players in the global Closed System Drug Transfer Device (CSTD) Market. These players have adopted different strategies such as product launch, expansion, partnership, collaboration and others, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Get Customized Reports with your Requirements - https://www.alliedmarketresearch.com/request-for-customization/A324072
Recent Developments in Closed System Drug Transfer Device (CSTD) Market Worldwide
- In December 2021, B. Braun Medical Inc., a leading provider of Closed System Drug Transfer Devices (CSTD), announced that the OnGuard 2 CSTD is now available in the U.S. OnGuard 2 incorporates all the current advantages of OnGuard, while offering upgraded materials and enhanced features to improve its usability.
Trending Reports in Healthcare Industry:
Erythropoietin Drugs Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Antifungal Drugs Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Antihypertensive Drugs Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
